|Bid||8,260.00 x 0|
|Ask||8,263.00 x 0|
|Day's range||8,179.72 - 8,281.00|
|52-week range||6,499.80 - 8,848.00|
|Beta (5Y monthly)||0.21|
|PE ratio (TTM)||38.05|
|Forward dividend & yield||2.07 (2.38%)|
|Ex-dividend date||25 Feb 2021|
|1y target est||N/A|
Dr. Michael Gonzalez, Emergency Medicine Physician & Assistant Professor at Baylor College of Medicine, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
(Bloomberg) -- The U.S. Centers for Disease Control and Prevention gave up a crucial tool for tracking the effectiveness of vaccines -- how many fully vaccinated people contract “breakthrough infections” -- just as the troublesome delta variant was emerging.Walmart Inc., the largest private employer in the U.S., is requiring its headquarters and regional staff to be vaccinated. Yale University is bringing back its indoor mask requirement for all, and Broadway theaters in New York City will also
Pfizer (PFE), Merck (MRK) and others announce Q2 results. FDA approves AbbVie's (ABBV) new antibiotic injection and expands use of Merck's Keytruda and Glaxo's Shingrix and Nucala.